In this case, the outcome of elevated BST‐2 in breast cancer is poor survival (Fig. 3, Box 5) as revealed by meta analyses of large human datasets 123, 131 and experimental evidence in mouse models of breast cancer 131. The gene discussed is BST2; the disease is breast carcinoma.